Guide

Is BPC-157 legal in the US?

No lawful route exists for personal use. BPC-157 is not FDA-approved for any human use, and as of September 2026 it is not on the list of substances US pharmacies may compound from. An FDA advisory committee voted 8 to 6 in July 2026 to recommend adding it, but that vote is not binding and nothing is final.

A gloved hand holds a graduated glass beaker of clear liquid in a bright modern laboratory.

Is BPC-157 FDA-approved?

No. BPC-157 is not approved for any use in people. FDA’s July 2026 briefing document found no studies giving BPC-157 to humans by injection, by mouth or by nose, and no information on how it behaves in the human body. FDA briefing, BPC-157

Macro shot of empty clear plastic tube tips standing in a bright blue and green laboratory tray.

A 2025 systematic review in orthopaedic sports medicine found 36 BPC-157 studies, 35 of them preclinical, and no clinical safety data. HSS J 2025

Can a pharmacy legally compound BPC-157?

Not today. A 503A pharmacy may compound from a bulk ingredient only if it meets federal criteria, such as appearing on FDA’s 503A bulks list, and FDA also tolerates Category 1 substances under an interim policy. BPC-157 qualifies under neither as of September 2026. The July 2026 advisory vote could change that, but only after FDA decides and completes rulemaking. 21 U.S.C. 353a

Bright blue liquid pours from a glass flask into a row of clear laboratory test tubes under clean lab light.
  1. Before 2026

    BPC-157 sits on FDA’s Category 2 list of bulk substances that may present significant safety risks. Orrick

  2. Apr 15, 2026

    FDA removes BPC-157 and 11 other peptides from Category 2 and schedules advisory committee review. Orrick

  3. Jul 23 to 24, 2026

    FDA’s Pharmacy Compounding Advisory Committee meets on peptides. FDA

  4. Jul 2026

    The committee votes 8 to 6 to recommend adding BPC-157 to the 503A bulks list for ulcerative colitis, after FDA staff recommended against it. McDermott Will & Schulte

  5. Next

    FDA decides whether to follow the vote and, if so, completes rulemaking. Until then there is no lawful compounding route. McDermott Will & Schulte

Is it legal to sell BPC-157 as a research chemical?

Not when it is marketed for people. FDA judges a product by how it is marketed, not by its disclaimer, and has sent warning letters to BPC-157 sellers whose sites promoted human use while labeling products “for research use only” and “not for human or veterinary use.” FDA warning letter

A clinician's hands, in a white coat with a stethoscope, writing on a clipboard beside a laptop on a bright wooden desk; no face visible.

FDA sent a similar warning letter to another peptide seller in December 2024. FDA warning letter

FDA’s reviewers also found BPC-157 is not well characterized, testing for impurities and contamination was lacking, and it may pose a significant risk of immune reactions. FDA briefing, BPC-157

Is BPC-157 banned in sport?

Yes. BPC-157 is prohibited at all times under the World Anti-Doping Agency’s 2026 list of non-approved substances. USADA says there are no human clinical trials establishing its efficacy and that it is unknown whether it is safe in any amount. USADA

What could change BPC-157’s legal status?

An FDA decision to add BPC-157 to the 503A bulks list, followed by final rulemaking, would let licensed pharmacies compound it on an individual prescription. That would still not make it an FDA-approved drug, and it would not make “research” products lawful for people. McDermott Will & Schulte

Looking for a lawful option?

See every compound in fitness, strength & recovery with its US status, evidence and risks. Only a licensed clinician who knows your history can decide what fits.

Is BPC-157 legal: questions, answered

Is BPC-157 illegal?

BPC-157 is not FDA-approved and cannot be lawfully compounded as of September 2026, so there is no lawful way to obtain it for human use. Selling it for human use has drawn FDA warning letters. It is also prohibited in sport under the WADA list.

Can a doctor prescribe BPC-157?

Not lawfully today. There is no FDA-approved BPC-157 product, and it is not on the list of ingredients pharmacies may compound from, so a licensed clinician has nothing lawful to prescribe. That could change only if FDA adds it to the 503A bulks list through rulemaking.

Did FDA approve BPC-157 in 2026?

No. In July 2026 an FDA advisory committee voted 8 to 6 to recommend adding BPC-157 to the compounding bulks list for ulcerative colitis. That is advice to FDA, not an approval, and FDA has to decide and complete rulemaking before anything changes.

Is BPC-157 safe?

Its safety in people is unknown. FDA found no studies giving it to humans by the routes it is marketed for, flagged a possible risk of immune reactions, and products sold online are not made to drug standards, so identity, purity and sterility are unverified.

Sources

  1. FDA briefing document for the July 2026 advisory committee: BPC-157
  2. Emerging use of BPC-157 in orthopaedic sports medicine: systematic review (HSS J 2025)
  3. 21 U.S.C. 353a: Pharmacy compounding, section 503A (US Code)
  4. FDA: Bulk drug substances that may present significant safety risks (Category 2)
  5. Orrick: FDA removes 12 peptides from Category 2 and schedules PCAC meetings (Apr 2026)
  6. FDA: Pharmacy Compounding Advisory Committee, July 23-24, 2026
  7. McDermott Will & Schulte: PCAC backs majority of peptides in two-day public meeting (July 2026)
  8. FDA warning letter: Peptide Partners (Aug 24, 2026)
  9. FDA warning letter: Summit Research Peptides (Dec 10, 2024)
  10. USADA: BPC-157, prohibited peptide
  11. WADA 2026 Prohibited List (PDF mirror)

Last reviewed September 23, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.

Compounds in this guide

BPC-157

peptide

A lab-made peptide popular for injury recovery. Mostly animal data, and not an approved drug.

Research onlyAnimal & lab studies only
Education only

TB-500

peptide

A synthetic fragment of thymosin beta-4 marketed for recovery. Animal data only; not approved.

Research onlyAnimal & lab studies only
Education only